Relapsing Forms of Multiple Sclerosis (RMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (GEMINI 2)

NCT04410991 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

899

Enrollment

INDUSTRY

Sponsor class

Conditions

Relapsing Multiple Sclerosis

Interventions

DRUG: Tolebrutinib
DRUG: Teriflunomide HMR1726
DRUG: Placebo to match Tolebrutinib
DRUG: Placebo to match Teriflunomide

Sponsor

Sanofi